SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+4.69%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$864M
AUM Growth
+$864M
(+2.8%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
48.36%
Holding
121
New
34
Increased
19
Reduced
27
Closed
25
Top Buys
| 1 |
Generac Holdings
GNRC
|
$13M |
| 2 |
Johnson & Johnson
JNJ
|
$11.9M |
| 3 |
BioXcel Therapeutics
BTAI
|
$11.7M |
| 4 |
Eli Lilly
LLY
|
$9.77M |
| 5 |
Meta Platforms (Facebook)
META
|
$9.17M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$41.2M |
| 2 |
Novo Nordisk
NVO
|
$26.2M |
| 3 |
Fiverr
FVRR
|
$15.2M |
| 4 |
Nice
NICE
|
$15.2M |
| 5 |
Q32 Bio
QTTB
|
$10M |
Sector Composition
| 1 | Healthcare | 83.14% |
| 2 | Technology | 6.68% |
| 3 | Consumer Discretionary | 3.03% |
| 4 | Industrials | 2.58% |
| 5 | Communication Services | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$210B
| $73.3M | 7.2% | 883,808 +100,000 | +13% | +$8.3M |
|
2
AbbVie
ABBV
$372B
| $69.2M | 6.8% | 790,000 +55,402 | +8% | +$4.85M |
|
|
3
Johnson & Johnson
JNJ
$427B
| $56.6M | 5.56% | 380,000 +80,000 | +27% | +$11.9M |
|
4
Sanofi
SNY
$121B
| $56.2M | 5.52% | 1,120,000 | – | – |
|
5
AstraZeneca
AZN
$248B
| $44.9M | 4.42% | 820,000 -70,000 | -8% | -$3.84M |
|
6
Amgen
AMGN
$155B
| $28M | 2.75% | 110,000 +30,000 | +38% | +$7.62M |
|
7
Novartis
NVS
$245B
| $24.8M | 2.44% | 285,000 +105,000 | +58% | +$9.13M |
|
8
Sarepta Therapeutics
SRPT
$1.78B
| $24.1M | 2.37% | 171,500 +48,300 | +39% | +$6.78M |
|
|
9
Eli Lilly
LLY
$657B
| $23.1M | 2.27% | 156,000 +66,000 | +73% | +$9.77M |
|
|
DCPH
10
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $17.6M | 1.73% | 343,965 +61,000 | +22% | +$3.13M |
|
11
Amicus Therapeutics
FOLD
$2.34B
| $17.6M | 1.73% | 1,243,550 -385,000 | -24% | -$5.44M |
|
12
Y-mAbs Therapeutics
YMAB
$388M
| $15.2M | 1.5% | 396,521 +114,269 | +40% | +$4.39M |
|
13
Teva Pharmaceuticals
TEVA
$21.1B
| $14.3M | 1.4% | 1,582,878 +1,000,000 | +172% | +$9.01M |
|
|
14
Nice
NICE
$8.73B
| $14.2M | 1.39% | 62,481 -66,925 | -52% | -$15.2M |
|
|
15
Generac Holdings
GNRC
$10.9B
| $13M | 1.27% | +67,000 | New | +$13M |
|
16
Amazon
AMZN
$2.44T
| $12M | 1.18% | 3,820 -500 | -12% | -$1.57M |
|
|
17
BioXcel Therapeutics
BTAI
$59M
| $11.7M | 1.15% | +269,300 | New | +$11.7M |
|
|
MYOK
18
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $11M | 1.09% | 81,000 -19,000 | -19% | -$2.59M |
|
19
Kura Oncology
KURA
$686M
| $11M | 1.08% | 359,494 -175,000 | -33% | -$5.36M |
|
20
Microsoft
MSFT
$3.77T
| $10.8M | 1.06% | 51,278 -30,686 | -37% | -$6.45M |
|
21
Allot
ALLT
$362M
| $9.51M | 0.93% | 1,045,337 +81,881 | +8% | +$745K |
|
22
Kornit Digital
KRNT
$669M
| $9.3M | 0.91% | 143,381 -33,126 | -19% | -$2.15M |
|
|
TRIL
23
DELISTED
Trillium Therapeutics Inc.
TRIL
| $9.17M | 0.9% | 645,435 -532,911 | -45% | -$7.57M |
|
|
24
Meta Platforms (Facebook)
META
$1.86T
| $9.17M | 0.9% | +35,000 | New | +$9.17M |
|
|
IMAB
25
I-MAB
IMAB
$340M
| $8.55M | 0.84% | +181,820 | New | +$8.55M |
|